C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 167/134,
C12N 15/51 (2006.01) A61K 39/29 (2006.01) C07K 14/02 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 15/81 (2006.01) C12P 21/02 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2021762
A composite particle comprising at least two polypeptides corresponding to all or part of a protein having the biological activity of one of the hepatitis B surface antigens, wherein the particle presents at least two antigenic determinants provided by the S-protein, preS2-protein or preS1-protein, said particle optionally further comprising host specific lipids. The invention also provides a modified hepatitis B surface antigen L protein which may be used alone or incorporated into such composite particles. A particular embodiment of the modified L protein (L*) comprises residues 12-52 followed by residues 133-145 followed by residues 175-400 of the L protein and a particular embodiment of a composite particle has the form (L*, S) where S is the S-protein of HBsAg. Improved hepatitis B vaccines may be prepared following expression of the above immunogens, especially in yeasts such as S. cerevisiae and Hansenula polymorpha.
Cabezon Teresa
Comberbach Martin
Harford Nigel
Hollenberg Cornelis P.
Jacobs Eric
Borden Ladner Gervais Llp
Smithkline Biologicals (s.a.)
LandOfFree
Antigens and methods therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigens and methods therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigens and methods therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1718494